Blockchain-based method and apparatus for managing sharing of reagents for research

Abstract

Disclosed are a blockchain-based method and apparatus for managing the sharing of reagents for research. A blockchain-based method for managing the sharing of reagents for research according to one embodiment disclosed herein may comprise the steps of: when reagent information is received from a first user terminal of a reagent provider, issuing a digital coin corresponding to the value of the reagent; providing the digital coin for the reagent and a blockchain-based ledger to the first user terminal; when a reagent purchase request is received from a second user terminal of a reagent purchaser, checking the inventory of the reagent requested by the second user terminal on the basis of the blockchain-based ledger; and when the reagent is in stock, requesting a payment of digital coins corresponding to the value of the reagent requested by the second user terminal.

Description

Blockchain-based method and device for managing the sharing of research reagents

[0001] This application claims the benefit of priority based on Korean Patent Application No. 10-2024-0138019 filed on October 10, 2024, and all contents disclosed in the document of said Korean patent application are incorporated herein as part of this specification.

[0002] The present disclosure relates to a blockchain-based method and apparatus for managing the sharing of research reagents, which provides a blockchain-based system to facilitate the sharing and distribution of research reagents.

[0003] In modern scientific research, research reagents are one of the core resources of experiments and play a crucial role in determining their success and accuracy. However, many research institutions face various difficulties in efficiently managing and sharing these reagents. In particular, the issue of research reagent supply is a significant obstacle for researchers in planning and conducting experiments.

[0004] Research institutions tend to purchase reagents in excess of what is necessary. This is because situations frequently arise where reagents are used for extended periods or require securing large quantities. However, such overpurchasing generates unnecessary inventory and can lead to wasted research funds. Reagents held in inventory may deteriorate or need to be discarded over time, potentially causing environmental problems. In particular, many research institutions struggle with managing discarded reagents, placing an additional burden on both research costs and the environment.

[0005] Furthermore, it is becoming increasingly difficult to rapidly procure reagents. Particularly for research reagents imported from overseas, the significant time required for customs clearance and transportation frequently results in situations where researchers are unable to immediately secure the reagents they need. This slows down the pace of research, significantly reducing efficiency and potentially undermining the nation's research competitiveness.

[0006] In particular, these reagent supply issues became even more severe during pandemics such as COVID-19. Disruptions in international logistics and supply chains caused by the pandemic led to serious delays in reagent delivery, resulting in the suspension or postponement of many research projects. This situation served as a stark reminder of the critical importance of a rapid supply system for research reagents.

[0007] Furthermore, there is a problem where surplus reagents are not effectively shared due to a lack of cooperation among research institutions. While large-scale research institutions generate a large amount of surplus reagents, small and medium-sized research institutes and universities often struggle to procure necessary reagents. The absence of such a reagent sharing system forces each institution to manage reagents independently, leading to duplicate purchases and unnecessary waste of resources.

[0008] The aforementioned background technology is technical information that the inventor possessed for the derivation of the present invention or acquired during the process of deriving the present invention, and it cannot be considered as prior art disclosed to the general public prior to the filing of the present invention.

[0009] One objective of the embodiments of the present disclosure is to enable research institutions to share surplus reagents they possess in a transparent and secure manner, and to ensure reliability by recording the quality and transaction history of the reagents on a blockchain.

[0010] One objective of the embodiments of the present disclosure is to enhance research efficiency by providing an environment in which researchers can quickly purchase and receive necessary reagents in small quantities.

[0011] One objective of the embodiments of the present disclosure is to provide an economic incentive for reagent sharing by providing reagent providers with compensation in the form of digital coins.

[0012] The purpose of the embodiments of the present disclosure is not limited to the problems mentioned above, and other unmentioned purposes and advantages of the present invention may be understood from the following description and will be more clearly understood by the embodiments of the present invention. Furthermore, it will be understood that the purposes and advantages of the present invention can be realized by the means and combinations thereof set forth in the claims.

[0013] A blockchain-based research reagent sharing management method according to one embodiment of the present disclosure is a blockchain-based research reagent sharing management method in which at least a portion of each step is performed by a processor, and may include: a step of issuing a digital coin corresponding to the value of the reagent when reagent information is received from a first user terminal of a reagent provider; a step of providing a digital coin and a blockchain-based ledger for the reagent to the first user terminal; a step of checking the inventory of the reagent requested by the second user terminal based on the blockchain-based ledger when a reagent purchase request is received from a second user terminal of a reagent buyer; and a step of requesting payment of a digital coin corresponding to the value of the reagent requested by the second user terminal when there is inventory.

[0014] In some examples, the step of issuing the digital coin may include: a step of evaluating the value according to the quality and quantity of the reagent provided from the first user terminal based on a preset valuation algorithm; and a step of issuing a digital coin according to the value of the reagent provided from the first user terminal and registering it in the blockchain ledger.

[0015] In some examples, when a digital coin is requested from the second user terminal, the method may further include the step of providing a digital coin from among the digital coins issued for the entire holding of reagents registered in the blockchain ledger.

[0016] In some examples, when a digital coin is requested from the second user terminal, the method may further include the step of performing a coin transaction between the first user terminal and the second user terminal within the coins held by the first user terminal.

[0017] In some examples, the method further includes the step of recording transaction details related to the registration, sharing, and distribution of reagents provided from the first user terminal in the blockchain ledger, and the transaction details in the blockchain ledger may be distributed and immutable.

[0018] In some examples, the method may further include the step of determining whether the corresponding reagent can be subdivided according to the quantity of the reagent requested from the second user terminal based on the blockchain ledger; and the step of allocating digital coins according to the subdivision.

[0019] In some examples, the method may further include the step of providing the source of the reagent, transaction history, quality evaluation record, and real-time inventory status to the first user terminal and the second user terminal.

[0020] In some examples, based on the blockchain ledger, if there is no stock of the reagent requested from the second user terminal or if the stock of the reagent is below a set level, the method may further include the step of requesting the necessary reagent from the first user terminal.

[0021] In some examples, when reagent information is received from the first user terminal, the method may further include a step of automatically performing subdivision and labeling of the reagent according to the reagent information.

[0022] A blockchain-based research reagent sharing management device according to one embodiment of the present disclosure comprises: a blockchain ledger that records transactions related to the registration, sharing, and distribution of reagents; a coin trading module that trades reagents using digital coins; a memory that stores at least one instruction; and at least one processor that executes the instruction in conjunction with the memory. When the instruction is executed by the processor, the processor is configured to issue a digital coin corresponding to the value of the reagent through the coin trading module when reagent information is received from a first user terminal of a reagent provider, and to provide the digital coin for the reagent and the blockchain-based ledger to the first user terminal; and when a reagent purchase request is received from a second user terminal of a reagent buyer, the processor is configured to check the inventory of the reagent requested by the second user terminal based on the blockchain-based ledger, and if there is inventory, to request payment of a digital coin corresponding to the value of the reagent requested by the second user terminal.

[0023] In addition to this, other methods for implementing the present invention, other systems, and computer-readable recording media storing a computer program for executing said methods may be further provided.

[0024] Other aspects, features, and advantages other than those described above will become clear from the following drawings, claims, and detailed description of the invention.

[0025] According to an embodiment of the present disclosure, by providing a system that allows surplus reagents to be shared among research institutions, the overpurchase of reagents can be prevented and the waste of research funds resulting therefrom can be significantly reduced. Additionally, each research institution can purchase only the amount of reagents needed in small quantities, thereby preventing the problem of spoilage or disposal of reagents due to long-term storage.

[0026] In addition, by enabling same-day or next-day delivery so that researchers can quickly secure necessary reagents, it is possible to accelerate the speed of research and maximize research efficiency by resolving the problem of research interruption or delay that may occur due to delays in the supply of reagents required for research.

[0027] Furthermore, because blockchain technology inherently prevents recorded information from being arbitrarily altered, it ensures trust in the process of providing and trading reagents. By utilizing blockchain technology to transparently record and manage all details regarding reagent registration, trading, and quality evaluation, the fairness and reliability of reagent management and trading can be significantly enhanced.

[0028] In addition, by resolving the problem of disposal caused by the overpurchase and deterioration of surplus reagents, unnecessary reagent waste can be reduced to prevent environmental pollution, and by ensuring that reagents are reused at other research institutions within their valid shelf life, efficient resource utilization can be promoted and environmental protection can be contributed.

[0029] In addition, by promoting the sharing of reagents among research institutions, opportunities for mutual cooperation are provided, and the efficient allocation of research resources is enabled, allowing not only large institutions but also small research institutes and universities to smoothly secure reagents, thereby reducing the burden of securing resources necessary for research progress.

[0030] In addition, providing economic rewards in the form of digital coins to research institutions or individuals who provide reagents can incentivize participation in reagent sharing, and these coins can serve as an additional financial incentive by allowing them to be used to purchase or trade other reagents within the platform.

[0031] In addition, by providing a system that allows research institutions to manage and verify reagent inventory in real time, and by transparently sharing and managing inventory status, each institution can identify necessary reagents in real time, avoid unnecessary purchases, and quickly secure them through immediate additional orders if needed reagents are in short supply.

[0032] In addition, through a rapid and efficient reagent supply and sharing system, researchers can more easily secure the resources needed for experiments, which significantly increases the overall efficiency of research, thereby enhancing the research competitiveness of the nation and institutions as well as greatly improving the quality of research outcomes.

[0033] The effects of the present invention are not limited to those mentioned above, and other unmentioned effects will be clearly understood by a person skilled in the art from the description below.

[0034] FIG. 1 is an exemplary diagram schematically illustrating a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure.

[0035] FIG. 2 is an illustrative diagram for explaining the overall overview of a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure.

[0036] FIG. 3 is an illustrative diagram for explaining the transaction flow of a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure.

[0037] FIG. 4 is an illustrative diagram for explaining a profit generation method of a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure.

[0038] FIG. 5 is a block diagram schematically illustrating a blockchain-based research reagent sharing management device according to one embodiment of the present disclosure.

[0039] FIG. 6 is a flowchart illustrating a blockchain-based research reagent sharing management method according to one embodiment of the present disclosure.

[0040] The advantages and features of the present invention, and the methods for achieving them, will become clear by referring to the embodiments described in detail together with the accompanying drawings. However, the present invention is not limited to the embodiments presented below, but can be implemented in various different forms and should be understood to include all modifications, equivalents, and substitutions that fall within the spirit and scope of the present invention. The embodiments presented below are provided to ensure that the disclosure of the present invention is complete and to fully inform those skilled in the art of the scope of the invention. In describing the present invention, detailed descriptions of related known technologies are omitted if it is determined that such detailed descriptions may obscure the essence of the present invention.

[0041] The terms used in this application are used merely to describe specific embodiments and are not intended to limit the invention. Singular expressions include plural expressions unless the context clearly indicates otherwise. In this application, terms such as “comprising” or “having” are intended to indicate the presence of the features, numbers, steps, actions, components, parts, or combinations thereof described in the specification, and should be understood as not precluding the existence or addition of one or more other features, numbers, steps, actions, components, parts, or combinations thereof. Terms such as “first,” “second,” etc., may be used to describe various components, but the components should not be limited by these terms. These terms are used solely for the purpose of distinguishing one component from another.

[0042] In addition, the term "coin" as used in this application includes not only cryptocurrency coins but also electronically provided or managed coupons, points, etc.

[0043] Hereinafter, embodiments according to the present invention will be described in detail with reference to the attached drawings. In describing with reference to the attached drawings, identical or corresponding components are given the same reference numerals, and redundant descriptions thereof will be omitted.

[0044] FIG. 1 is an exemplary diagram schematically illustrating a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure, FIG. 2 is an exemplary diagram explaining the overall overview of a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure, and FIG. 3 is an exemplary diagram explaining the transaction flow of a blockchain-based research reagent sharing management system according to one embodiment of the present disclosure.

[0045] Referring to FIG. 1, a blockchain-based research reagent sharing management system (1) may include a research reagent sharing management device (100), a user terminal (200), a server (300), and a network (400).

[0046] In some examples, the blockchain-based research reagent sharing management system (1) is related to the management of research reagents, and specifically to a research reagent management system designed to facilitate the sharing, storage, and distribution of reagents among research institutions. In the modern research environment, waste of reagents occurs due to supply chain delays, overpurchases, and improper storage in the management of reagents, leading to problems such as increased research costs and environmental pollution. Additionally, unnecessary costs are incurred because the sharing of reagents among research institutions is not carried out efficiently. Accordingly, the blockchain-based research reagent sharing management system (1) aims to reduce research costs and reagent waste by sharing surplus reagents held by research institutions through a blockchain-based system and managing them transparently and quickly.

[0047] In some examples, the blockchain-based research reagent sharing management system (1) can establish a system for efficiently sharing and managing research reagents through a distributed blockchain-based platform. Additionally, the blockchain-based research reagent sharing management system (1) introduces a coin economy using digital tokens, allowing researchers to purchase or sell necessary reagents in small quantities, thereby ensuring transparency and reliability of reagent transactions through the blockchain.

[0048] In some examples, the blockchain-based research reagent sharing management system (1) allows institutions or researchers holding surplus reagents to register the reagents on the platform, evaluate the quality of the reagents, and calculate their value, and the reagents that have been evaluated can be registered on the blockchain. In some examples, the blockchain-based research reagent sharing management system (1) assigns a value to each reagent in the form of a digital token based on its quality and quantity, and allows researchers to purchase the reagents in small quantities using these tokens. In some examples, the blockchain-based research reagent sharing management system (1) can be delivered quickly to researchers via a rapid delivery system, and same-day or next-day delivery can be supported. In some examples, the blockchain-based research reagent sharing management system (1) conducts quality inspections on all reagents before registration, excludes reagents that do not meet the standards from transactions, and can transparently store quality inspection records through the blockchain. In some examples, a blockchain-based research reagent sharing management system (1) may reward users who provide surplus reagents with digital tokens, and the reward tokens may be used to purchase other reagents.

[0049] In some examples, the blockchain-based research reagent sharing management system (1) creates an inventory pool by receiving reagent materials that companies store individually for free, ensures the transparency of the reagent ledger using blockchain technology, and allows the reagent material provider to quickly purchase exactly the amount of reagent materials needed on the same day or the next day with the coins (tokens) received after calculating their value. Through this, it is a reagent material sharing business model that seeks profit through various transaction methods while creating and distributing a smooth flow of reagent resources without delays in research or excess inventory.

[0050] Referring to FIG. 2, in a blockchain-based research reagent sharing management system (1), the business entity evaluates the quality of reagent materials donated free of charge by corporate or individual reagent providers, compensates with coins (tokens) corresponding to the adjusted value, provides a blockchain-based ledger with ensured transparency, and establishes a reagent inventory pool. Users of reagent materials can purchase the amount of reagent materials they need through the business entity, rather than standardized units available on the market, using coins (tokens) they possess or have purchased. In some examples, the business entity may refer to the blockchain-based research reagent sharing management system (1).

[0051] As illustrated in Fig. 2, the business entity evaluates the value of experimental reagents, pays coins equivalent to that value in exchange for their provision, and can establish a ledger of the reagent inventory through a private blockchain system to ensure transparency. Additionally, the reagent provider can share the coins corresponding to the evaluated value of the reagents and the blockchainized inventory ledger. In other words, they can share the transparency of reagent inventory management through the blockchain ledger. Furthermore, the reagent provider can use the received coins to purchase other necessary reagents or to purchase reagents they have provided in smaller quantities through the business entity. Additionally, buyers who have not provided reagents can pay a membership fee to become members, purchase coins from the business entity, and then purchase necessary reagents in smaller quantities. Moreover, the reagent provider who has secured coins can trade them with members who wish to purchase reagents through the business entity. In addition, when the provided reagents are depleted, the business entity may purchase additional reagents from domestic and foreign reagent suppliers and include them in the blockchain system inventory, issuing coins equivalent to their value, and may sell the allocated coins to registered members or reagent providers who wish to purchase coins.

[0052] Referring to Fig. 3, if there are no quality issues with the received reagents, the business entity can evaluate their value based on the minimum quantity price in the corresponding reagent catalog. Since the evaluated reagents are used reagents and various costs for future sales must be incurred, the value may be adjusted. For example, if 20ml of reagent costs 100,000 won and the provided reagent is 10ml, the value may be set at 25,000 won after a 50% adjustment. In some cases, the business entity may create a blockchain-based ledger that guarantees transparency regarding the provided reagents and disclose the corresponding coins and ledger to the reagent provider. Additionally, reagent buyers, including the provider, can purchase subdivided reagents by paying coins for the amount required for the experiment. Furthermore, for items with running low stock, the business entity can purchase and restock them, generating the corresponding coins to be used for the business.

[0053] Referring to FIG. 4, profit generation in the blockchain-based research reagent sharing management system (1) can be performed by four methods.

[0054] First, a reagent provider offers unused surplus reagents to a business entity, and the business entity can evaluate the value of the reagents after performing a quality assessment. The business entity can then record the evaluated reagents and issue digital coins based on this. The value of the reagents is calculated as half of the minimum unit price specified in the catalog through value adjustment, and some operating expenses can be secured upon sale. For example, if 20 mL of reagent costs 100,000 won, 10 mL can be evaluated at 50,000 won and then adjusted to half of that, 25,000 won.

[0055] Secondly, members who do not provide reagents can join the platform by paying a membership fee to the business entity without providing any reagents. When members wish to purchase reagents, they can buy the necessary reagents through the platform. The membership fees and transaction fees generated when members who do not provide reagents purchase them can return as profit to the business entity.

[0056] Thirdly, reagent providers can provide surplus reagents in exchange for digital coins, which can then be used to purchase other reagents. After going through procedures such as subdividing and labeling the reagents, the business entity can earn a profit from the difference between the reagent selling price and the value-added price through sales. In other words, when reagents are subdivided and sold, a difference may arise between the cost of purchasing a large quantity of reagents and the amount obtained from the subdivided sales. Through this process, both reagent providers and buyers transact using digital coins, and the business entity can generate profits through the issuance and trading of coins.

[0057] Fourth, reagents can be purchased in bulk from domestic and international suppliers and then resold in smaller quantities. By purchasing in bulk, the business entity acquires reagents at wholesale prices and generates profit through the difference in volume and wholesale discounts by repackaging and selling them at retail prices. In this manner, in the long term, once the provided reagents are depleted, the business entity can purchase new reagents and register them on the platform, thereby generating a steady revenue stream.

[0058] In all of the above processes, digital coins are used as a means of intermediary for transactions; reagent providers and buyers trade reagents using coins, and the business entity can earn profits from each transaction process.

[0059] In the blockchain-based research reagent sharing management system (1), users can access an application implemented on a user terminal (200) to perform the entire process of sharing, distributing, and managing reagents. However, this is not limited to this, and according to the embodiment, it can be performed as in the application simply by accessing a website.

[0060] Meanwhile, in one embodiment, the user may include a reagent provider, a reagent purchaser, and a manager who performs reagent management, as described above. In some examples, the reagent provider may be capable of both providing reagents and purchasing reagents, and for convenience of explanation, they are described separately. In some examples, the user terminal (200) may include a first user terminal (210) of the reagent provider, a second user terminal (220) of the reagent purchaser, and a third user terminal (230) of the manager.

[0061] Such a user terminal (200) can receive reagent sharing management services through an authentication process after accessing a reagent sharing management application or a reagent sharing management website. The authentication process may include authentication for entering user information, such as membership registration, and authentication of the user terminal, but is not limited thereto; the authentication process may also be performed simply by accessing a link transmitted from a research reagent sharing management device (100) and / or a server (300).

[0062] In some examples, the user terminal (200) may be a desktop computer, smartphone, laptop, tablet PC, smart TV, mobile phone, PDA (personal digital assistant), laptop, media player, micro server, GPS (global positioning system) device, e-book reader, digital broadcasting terminal, navigation, kiosk, MP3 player, digital camera, home appliance, and other mobile or non-mobile computing devices operated by the user, but is not limited thereto. Additionally, the user terminal (200) may be a wearable terminal such as a watch, glasses, hair band, and ring equipped with communication functions and data processing functions. The user terminal (200) is not limited to the above-mentioned items, and any terminal capable of web browsing may be used without restriction.

[0063] Meanwhile, in some examples, the blockchain-based research reagent sharing management system (1) may be implemented by a research reagent sharing management device (100) and / or a server (300).

[0064] The server (300) is a server for operating the research reagent sharing management device (100), and can receive and analyze service request information from a user terminal (200), generate service response information corresponding to the service request information, and transmit it to the user terminal (200). In addition, the server (300) may be a server responsible for operating various devices so that the research reagent sharing management process can be performed smoothly, for example, by managing and overseeing the configurations of the research reagent sharing management device (100), as well as the new registration of related devices and network environments.

[0065] Additionally, the server (300) may include a database server that provides data for operating the research reagent sharing management device (100), and may also include a database server that provides big data necessary for applying various artificial intelligence algorithms.

[0066] And the server (300) may include an authentication server for authentication of a user terminal (200) that has accessed a reagent sharing management application or a reagent sharing management website, a server for instant messaging services, etc., or network with such servers.

[0067] In the case of a server for an instant messaging service, a chat room can be created for the accounts of users utilizing the instant messaging service to enable chatting between users and administrators involved in reagent sharing and purchasing.

[0068] Also, in the case of a server for an instant messaging service, it may be, for example, a single server computer or a similar system, or a plurality of servers arranged in one or more server banks or other arrangements. And the server for an instant messaging service may be located in a single facility, or it may be a server "cloud" distributed across many different geographical locations.

[0069] At this time, the user terminal (200) is a terminal capable of receiving instant messaging services and / or social network services, and can process a user interface or user interaction through a processor, or provide the processing result to a server (300) for instant messaging services. At this time, an instant messenger application may be separately installed and run on the user terminal (200), but in the blockchain-based research reagent sharing management system (1), a chat room based on instant messages may be created within the application for managing research reagents.

[0070] In some examples, the server (300) may include a blockchain server. A blockchain server is one of the central components of a blockchain network and may be referred to as a node. In blockchain, the term 'server' may differ somewhat from the traditional concept of a centralized server. Because a blockchain operates in a decentralized network, a blockchain server may refer to a distributed computer system that participates in the network to store, verify, and add new blocks of data. A blockchain server (node) can play a key role in ensuring the smooth operation of the blockchain network and the transparency, reliability, and security of the data.

[0071] The network (400) can perform the role of connecting the research reagent sharing management device (100), user terminal (200), and server (300) in the blockchain-based research reagent sharing management system (1). This network (400) may include wired networks such as LANs (local area networks), WANs (wide area networks), MANs (metropolitan area networks), and ISDNs (integrated service digital networks), or wireless networks such as wireless LANs, CDMA, Bluetooth, and satellite communication, but the scope of the present invention is not limited thereto. Additionally, the network (400) can transmit and receive information using short-range communication and / or long-range communication. Here, short-range communication may include Bluetooth, RFID (radio frequency identification), infrared communication (IrDA, infrared data association), UWB (ultra-wideband), ZigBee, and Wi-Fi (Wireless fidelity) technologies, and long-range communication may include CDMA (code division multiple access), FDMA (frequency division multiple access), TDMA (time division multiple access), OFDMA (orthogonal frequency division multiple access), and SC-FDMA (single carrier frequency division multiple access) technologies.

[0072] Additionally, the network (400) may include connections of network elements such as hubs, bridges, routers, switches, and gateways. The network (400) may include one or more connected networks, such as a multi-network environment, including a public network such as the Internet and a private network such as a secure corporate private network. Access to the network (400) may be provided through one or more wired or wireless access networks. Furthermore, the network (400) may support an Internet of Things (IoT) network and / or 5G communication that exchanges and processes information between distributed components, such as objects.

[0073] FIG. 5 is a block diagram schematically illustrating a blockchain-based research reagent sharing management device according to one embodiment of the present disclosure.

[0074] Referring to FIG. 5, a research reagent sharing management device (100) may include a communication interface (110), a user interface (120), a memory (130), and a processor (140). In some examples, the processor (140) may be connected to a blockchain ledger (10) and a coin transaction module (20), which may be done by the communication interface (110).

[0075] The communication interface (110) can enable communication between the first user terminal (210) and the second user terminal (220). The communication interface (110) may be a communication interface necessary to provide transmission and reception signals in the form of packet data between the server (300), the user terminal (200), and / or the research reagent sharing management device (100) in the blockchain-based research reagent sharing management system (1) in conjunction with the network (400). Additionally, the communication interface (110) may support various types of intelligent object communication (IoT (internet of things), IoE (internet of everything), IoST (internet of small things), etc.) and may support M2M (machine to machine) communication, V2X (vehicle to everything communication), D2D (device to device) communication, etc.

[0076] The user interface (120) may include an input interface that allows the user to perform actions to use the services provided by the research reagent sharing management device (100) and / or server (300), and an output interface that allows the user to check the services provided by the research reagent sharing management device (100) and / or server (300).

[0077] And the input interface may be configured to allow an administrator to input information regarding the overall operation and management (control) of the research reagent sharing management device (100) and / or server (300).

[0078] Meanwhile, the user interface (120) may be implemented on the user terminal (200). For example, according to one embodiment, the user terminal (200) may be able to request the provision and purchase of reagents through the screen (page) of the reagent sharing management application and / or reagent sharing management website, or output inventory status based on a blockchain ledger. Additionally, according to one embodiment, the user terminal (200) may be able to manage reagent providers, manage reagent inventory, manage reagent buyers, etc., through the screen (page) of the reagent sharing management application and / or reagent sharing management website, and may be able to perform settings management of the reagent sharing management application and / or reagent sharing management website.

[0079] The memory (130) is connected to one or more processors (140) and can store codes that, when executed by the processors (140), cause the processors (140) to support various functions of the entire blockchain-based research reagent sharing management system (1).

[0080] That is, the memory (130) can store a number of applications (application programs or applications) running throughout the blockchain-based research reagent sharing management system (1), information for the operation of the blockchain-based research reagent sharing management system (1), and commands. At least some of these applications can be downloaded from an external server via wireless communication. Additionally, the memory (130) can store information on one or more users who wish to interact with the blockchain-based research reagent sharing management system (1).

[0081] According to one embodiment, the memory (130) may perform the function of temporarily or permanently storing data processed by the processor (140). Here, the memory (130) may include a magnetic storage medium or a flash storage medium, but the scope of the present invention is not limited thereto. The memory (130) may include an internal memory and / or an external memory, and may include a volatile memory such as DRAM, SRAM, or SDRAM, a non-volatile memory such as OTPROM (one time programmable ROM), PROM, EPROM, EEPROM, mask ROM, flash ROM, NAND flash memory, or NOR flash memory, a flash drive such as an SSD, CF (compact flash) card, SD card, Micro-SD card, Mini-SD card, Xd card, or memory stick, or a storage device such as an HDD.

[0082] The processor (140) is a type of central processing unit that can control the entire blockchain-based research reagent sharing management system (1) by running control software installed in memory (130).

[0083] FIG. 6 is a flowchart illustrating a blockchain-based research reagent sharing management method according to one embodiment of the present disclosure.

[0084] Hereinafter, with reference to FIG. 6, a series of processes for managing the sharing of research reagents of the processor (140) will be described in more detail. These processes are described in steps for convenience of explanation, but can be performed regardless of the order.

[0085] In step S1, the processor (140) receives a reagent from the first user terminal (210) of the reagent provider. That is, the processor (140) may receive reagent information along with the provision of the reagent from the first user terminal (210). The reagent information may include reagent-related information such as the termination of the reagent and the quantity of the reagent.

[0086] In step S2, when a request for membership is made from the second user terminal (220), the processor (140) may approve the membership of the second user terminal (220). The second user terminal (220) is a terminal of a reagent buyer, and the reagent buyer can purchase digital coins after paying a membership fee and becoming a member during the membership process.

[0087] In steps S3 and S4, the processor (140) evaluates the value of the reagent based on the quality and quantity of the reagent provided by the first user terminal (210) based on a pre-set value evaluation algorithm, and can issue a digital coin corresponding to the value of the reagent through the coin trading module (20).

[0088] In some examples, the pre-configured valuation algorithm may be a learning model configured to enable valuation based on the type of reagent, the quality of the reagent, and its quantity. Such a learning model may be learned through the correlation between the type of reagent, the quality of the reagent, and its value. In some examples, the pre-configured valuation algorithm may be an algorithm configured to determine value based on a database of the type of reagent, the quality of the reagent, and its quantity.

[0089] In step S5, when the reagent value evaluation is completed, the processor (140) can generate a digital coin corresponding to the value of the reagent through the coin trading module (20) and pay it to the first user terminal (210).

[0090] In step S6, the processor (140) may provide digital coins to the second user terminal (220) if the second user terminal (220) needs digital coins to purchase reagents and wishes to purchase digital coins. In some examples, when digital coins are requested from the second user terminal (220), the processor (140) may provide digital coins from the digital coins issued for the entire holding of reagents registered in the blockchain ledger.

[0091] In step S7, the processor (140) may issue digital coins based on the value of the reagent provided by the first user terminal (210) and register them in the blockchain ledger (10). Additionally, the processor (140) may also register the details of digital coin transactions with the first user terminal (210) and the second user terminal (220) in the blockchain ledger (10). That is, the details of digital coin issuance and transactions may be registered in the blockchain ledger, and all transactions and reagent value assessment details may be transparently recorded and traceable.

[0092] In step S8, the processor (140) can provide ledger data recorded on the blockchain to the first user terminal (210). Additionally, the processor (140) can also provide blockchain ledger data to the second user terminal (220). Through this, each user can verify the transparency of transaction history and reagent information.

[0093] In some examples, the processor (140) may record transaction details related to the registration, sharing, and distribution of reagents provided from the first user terminal (210) in a blockchain ledger. The transaction details in this blockchain ledger may be distributed and immutable.

[0094] In steps S9 and S10, when the processor (140) receives a reagent purchase request from the second user terminal (220) of the reagent buyer, it can check the inventory of the reagent requested by the second user terminal (220) based on a blockchain-based ledger.

[0095] In some examples, the processor (140) can check whether the reagent can be subdivided according to the quantity of the reagent requested from the second user terminal (220) based on the blockchain ledger. In some examples, when the processor (140) receives reagent information from the first user terminal (210), it can automatically perform subdivision and labeling of the reagent according to the reagent information.

[0096] In step S11, the processor (140) may allocate digital coins according to the subdivision and request a digital coin payment corresponding to the value of the reagent requested by the second user terminal (220).

[0097] In steps S212 and S13, the processor (140) can deliver the reagent to the reagent buyer when the digital coin required for purchasing the reagent is paid at the second user terminal (220). That is, the delivery procedure can be carried out once the reagent is successfully purchased.

[0098] Meanwhile, in steps S14 and S15, the processor (140), based on the blockchain ledger (10), may request the necessary reagent from the first user terminal (210) if there is no stock of the reagent requested by the second user terminal (220) or if the stock of the reagent is below a set level. At this time, if the reagent provider has the reagent, it may provide it.

[0099] Additionally, when the provided reagents are depleted, the processor (140) can request reagents from domestic and international reagent suppliers to purchase additional ones. By including this in the blockchain ledger (10), coins corresponding to its value can be issued. These coins can be sold to registered members or reagent suppliers who wish to purchase coins.

[0100] That is, at step S16, the processor (140) can enable a digital coin transaction to take place between the first user terminal (210) and the second user terminal (220). Additionally, a transaction between the processor (140) and the first user terminal (210), and a transaction between the processor (140) and the second user terminal (220) can also take place. In some examples, when a coin transaction occurs between the first user terminal (210) and the second user terminal (220), the coin transaction can be performed within the coins held by the first user terminal (210).

[0101] These processes, such as coin trading and reagent registration, can be registered in the blockchain ledger (10), and the processor (140) can provide the source of the reagent, transaction history, quality evaluation records, and real-time inventory status to the first user terminal (210) and the second user terminal (220).

[0102] Such a processor (140) may refer to a data processing device embedded in hardware having a physically structured circuit to perform a function expressed by code or instructions included in a program, for example. Examples of such data processing devices embedded in hardware may include a microprocessor, a central processing unit (CPU), a processor core, a multiprocessor, an application-specific integrated circuit (ASIC), a field programmable gate array (FPGA), etc., but the scope of the present invention is not limited thereto.

[0103] In some examples, digital coin trading can serve as an important intermediary in reagent trading based on blockchain technology. It provides researchers with a means to buy, sell, or trade reagents, thereby increasing the efficiency of reagent sharing systems.

[0104] In some examples, when a reagent provider offers surplus reagents to the platform, the quality and value of the reagents are assessed, and the provider may receive digital coins as compensation based on the assessed value of the reagents. These coins serve as digital assets that can function as currency for trading or using reagents within the platform. For instance, if 10 mL of reagent is assessed to be worth 50,000 won, 50 corresponding digital coins may be issued. The provider can use these coins to purchase other reagents or sell them to other researchers.

[0105] In some examples, reagent buyers can purchase reagents using digital coins provided on the platform. Reagents can be purchased in small quantities as needed, allowing transactions to be conducted using the exact amount of coins. For instance, when a reagent buyer needs 5 mL of reagent, they can purchase it using 25 corresponding coins. This enables researchers to purchase the exact amount of reagent without overpurchasing.

[0106] In some examples, reagent providers can use issued coins to purchase other reagents or sell them to other researchers. For instance, a reagent provider can sell the coins received for providing reagents to other researchers or use those coins to purchase other reagents they need. This process generates liquidity for the coins, allowing reagents to be traded through them. In some examples, by introducing the concept of a coin exchange, coins can be traded in a structure where reagent providers sell the coins they received to other researchers, who then use those coins to purchase reagents.

[0107] In some cases, researchers who have not provided reagents must purchase coins with cash because they do not possess coins. After paying a membership fee and becoming a member of the platform, they can purchase digital coins from the operator using cash. For instance, if a researcher wishing to purchase reagents does not possess coins, they can purchase 50 coins with cash and use them to buy a small amount of reagents. Through this process, researchers come to possess coins and can use them to purchase the necessary reagents.

[0108] In some examples, when the stock of a specific reagent is depleted, a new reagent can be purchased and registered on the platform. When a new reagent is registered on the platform, additional coins corresponding to that reagent may be issued. These coins can then be used or traded by reagent providers or buyers. This system can regulate the supply and demand of coins to ensure smooth reagent trading.

[0109] In some examples, coins are given as compensation to reagent providers and used as a means of transaction for reagent buyers. Researchers can trade coins among themselves and can also sell them to other researchers to convert them into cash when necessary. Additionally, resource waste can be minimized because coins can be accumulated to purchase the exact amount of reagents needed when required.

[0110] In some examples, blockchain database and ledger technologies serve as core components of blockchain systems, enabling the transparent recording and management of all transactions and data on a distributed network. Unlike centralized databases, this technology allows multiple participants to contribute equally and store data in an immutable manner. This ensures data transparency, immutability, and security.

[0111] In some examples, data in a blockchain is stored in blocks. Each block contains one or more transaction records, and in addition to the transaction data, the block includes connection information (hash) to the previous block. This establishes connections between blocks. Blocks are linked sequentially, and each block holds the hash value of the previous block, creating an immutable record. Due to this structure, a blockchain can record data in a sequential and immutable manner. A blockchain stores identical data by replicating it on all nodes (computers) participating in the network, without a central server. This is called distributed data storage, and it prevents data from being manipulated in a single location. Since each participant can verify all blocks, data transparency is guaranteed.

[0112] In the context of blockchain, a ledger refers to a register where all transaction records are stored. While similar in concept to ledgers in traditional finance or accounting, in blockchain, it is a digitized ledger that is shared with all participants and can be updated in real time. In a blockchain, the ledger is not managed solely by a central server; instead, all nodes connected to the network can maintain the same ledger. This is known as Distributed Ledger Technology (DLT), which enables all nodes to access the ledger and share the same data. Data recorded in a blockchain ledger is immutable. Once recorded, transactions are stored permanently, and no one can modify or delete them. This ensures that all transactions recorded in the ledger are transparent and trustworthy. Adding a new transaction to a blockchain ledger may require consensus among network participants. Consensus algorithms (e.g., Proof of Work, Proof of Stake) are processes that verify the validity of transactions on the network and allow them to be recorded in the ledger. Through this, all participants possess the same record, guaranteeing the accuracy and reliability of the data.

[0113] In other words, in some cases, blockchain is used in research reagent trading and management systems to record and track the registration, trading, and quality evaluation of reagents on a blockchain ledger. This allows researchers to trust the origin and transaction history of reagents and enables transparent management of the reagents.

[0114] The embodiments according to the present invention described above may be implemented in the form of a computer program that can be executed through various components on a computer, and such a computer program may be recorded on a computer-readable medium. In this case, the medium may include a magnetic medium such as a hard disk, a floppy disk, and a magnetic tape, an optical recording medium such as a CD-ROM and a DVD, a magneto-optical medium such as a floptical disk, and a hardware device specifically configured to store and execute program instructions, such as a ROM, RAM, flash memory, etc.

[0115] Meanwhile, the above computer program may be specially designed and configured for the present invention, or it may be known and available to a person skilled in the art of computer software. Examples of computer programs may include not only machine code, such as that generated by a compiler, but also high-level language code that can be executed by a computer using an interpreter, etc.

[0116] In the specification of the present invention (particularly in the claims), the use of the term "above" and similar descriptive terms may be in both singular and plural. Furthermore, where a range is described in the present invention, it is to include an invention to which individual values ​​belonging to said range are applied (unless otherwise stated), and this is equivalent to describing each individual value constituting said range in the detailed description of the invention.

[0117] Unless explicitly stated or contrary to the order of the steps constituting the method according to the present invention, said steps may be performed in a suitable order. The present invention is not necessarily limited by the order in which said steps are described. The use of all examples or exemplary terms (e.g., etc.) in the present invention is merely for the purpose of describing the present invention in detail, and the scope of the present invention is not limited by said examples or exemplary terms unless limited by the claims. Furthermore, a person skilled in the art will understand that various modifications, combinations, and changes may be made according to design conditions and factors within the scope of the claims or equivalents to which they are added.

[0118] Accordingly, the scope of the present invention should not be limited to the embodiments described above, and all scopes equivalent to or equivalently modified from the claims set forth below, as well as the claims set forth below, shall be considered to fall within the scope of the concept of the present invention.

[0119]

[0120] Explanation of the symbols

[0121] 1 : Blockchain-based research reagent sharing management system

[0122] 10: Blockchain Ledger

[0123] 20: Coin Trading Module

[0124] 100: Research reagent sharing management device

[0125] 110: Communication interface

[0126] 120 : User Interface

[0127] 130 : Memory

[0128] 140 : Processor

[0129] 200 : User terminal

[0130] 300 : Server

[0131] 400 : Network

Claims

1. A blockchain-based research reagent sharing management method in which at least part of each step is performed by a processor, When reagent information is received from a first user terminal of a reagent provider, a step of issuing a digital coin corresponding to the value of the reagent; A step of providing a digital coin and a blockchain-based ledger for the above-mentioned reagent to the first user terminal; When a reagent purchase request is received from a second user terminal of a reagent purchaser, a step of verifying the inventory of the reagent requested by the second user terminal based on the blockchain-based ledger; and A blockchain-based research reagent sharing management method comprising the step of requesting payment of digital coins corresponding to the value of the reagent requested by the second user terminal when there is stock.

2. In Paragraph 1, The step of issuing the above digital coin is, A step of evaluating the value according to the quality and quantity of the reagent provided from the first user terminal based on a pre-set value evaluation algorithm; and A blockchain-based research reagent sharing management method comprising the step of issuing digital coins based on the value of the reagent provided from the first user terminal and registering them in the blockchain ledger.

3. In Paragraph 1, A blockchain-based research reagent sharing management method further comprising the step of providing digital coins from among the digital coins issued for all reagents registered in the blockchain ledger when a digital coin is requested from the second user terminal.

4. In Paragraph 1, A blockchain-based method for managing the sharing of research reagents, further comprising the step of performing a coin transaction between the first user terminal and the second user terminal within the coins held by the first user terminal when a digital coin is requested from the second user terminal.

5. In Paragraph 1, The method further includes the step of recording transaction details related to the registration, sharing, and distribution of reagents provided from the first user terminal in the blockchain ledger. A blockchain-based method for managing the sharing of research reagents, wherein the transaction history of the above-mentioned blockchain ledger is stored in a distributed manner and is immutable.

6. In Paragraph 1, A step of confirming whether the corresponding reagent can be subdivided according to the quantity of the reagent requested from the second user terminal based on the blockchain ledger; and A blockchain-based research reagent sharing management method further comprising the step of allocating digital coins according to the above subdivision.

7. In Paragraph 1, A blockchain-based research reagent sharing management method further comprising the step of providing the source, transaction history, quality evaluation record, and real-time inventory status of the reagent to the first user terminal and the second user terminal.

8. In Paragraph 1, A blockchain-based research reagent sharing management method, further comprising the step of requesting a necessary reagent from a first user terminal when there is no stock of the reagent requested from the second user terminal or when the stock of the reagent is below a set level, based on the blockchain ledger.

9. In Paragraph 1, A blockchain-based research reagent sharing management method further comprising the step of automatically performing subdivision and labeling of the reagent according to the reagent information when reagent information is received from the first user terminal.

10. As a blockchain-based research reagent sharing management device, A blockchain ledger that records transactions related to the registration, sharing, and distribution of reagents; A coin trading module for trading reagents using digital coins; Memory for storing at least one instruction; and At least one processor that executes the above instructions in conjunction with the above memory Including, When the above command is executed by the processor, the processor causes, upon receiving reagent information from the first user terminal of the reagent provider, to issue a digital coin corresponding to the value of the reagent through the coin transaction module, A digital coin for the above reagent and the above blockchain-based ledger are provided to the above first user terminal, When a reagent purchase request is received from a second user terminal of a reagent purchaser, the inventory of the reagent requested by the second user terminal is checked based on the blockchain-based ledger, and A blockchain-based research reagent sharing management method configured to request payment of digital coins corresponding to the value of the reagent requested by the second user terminal when there is stock.

Images